These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 13945019)

  • 1. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 3. INITIAL EXPERIENCE WITH THROMBOTEST.
    MILLER AL; FARRER-BROWN G; PETHER J
    J Clin Pathol; 1964 Mar; 17(2):182-4. PubMed ID: 14149946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPY.
    SEVITT S; INNES D
    Lancet; 1964 Jan; 1(7325):124-9. PubMed ID: 14074476
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of phenylindanedione on the coagulation factors prothrombin, factor V and factor VII and the question of vitamin K resistance].
    PERLICK E
    Klin Wochenschr; 1953 Mar; 31(11-12):261-3. PubMed ID: 13070456
    [No Abstract]   [Full Text] [Related]  

  • 6. [Owren's method for quantitative prothrombin-proconvertin determination in control of anticoagulant therapy].
    LUND E
    Ugeskr Laeger; 1953 May; 115(21):801-5. PubMed ID: 13077997
    [No Abstract]   [Full Text] [Related]  

  • 7. OMEPHINE, A NEW ANTICOAGULANT.
    KOPTELOVA MN
    Fed Proc Transl Suppl; 1963; 22():1256-8. PubMed ID: 14079350
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of the relationship of concentrations of prothrombin, proconvertin, and proaccelerin to three methods for measuring prothrombin time.
    GONYEA LM; HJORT P; OWREN PA
    J Lab Clin Med; 1956 Oct; 48(4):624-33. PubMed ID: 13367602
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of laboratory methods for the control of anticoagulant therapy with prothrombinopenic agents. I. The Quick one-stage procedure, the prothrombin and proconvertin test and the one-stage determination of true prothrombin activity.
    RODMAN T; PASTOR BH; FAWCETT KC
    Am J Med; 1961 Oct; 31():547-54. PubMed ID: 14493137
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analytical study on Quick test; determination of prothrombin, proconvertin, and proaccelerin].
    SOULIER JP; LARRIEU MJ
    Sang; 1952; 23(7):549-59. PubMed ID: 13004906
    [No Abstract]   [Full Text] [Related]  

  • 11. Prothrombin and proconvertin in the newborn and during the first year of life.
    DYGGVE H
    Acta Paediatr (Stockh); 1958 May; 47(3):251-9. PubMed ID: 13532682
    [No Abstract]   [Full Text] [Related]  

  • 12. CONTROLLED STUDY OF THE EFFECTIVE LEVEL OF LONG-TERM ANTICOAGULATION.
    MOSCHOS CB; WONG PC; SISE HS
    JAMA; 1964 Nov; 190():799-805. PubMed ID: 14202822
    [No Abstract]   [Full Text] [Related]  

  • 13. The blood coagulation mechanism with especial reference to the prothrombin-proconvertin contents of plasma during long-term ACTH or cortisone therapy.
    FISCHER F; LUND E
    Acta Med Scand; 1954; 149(3):179-85. PubMed ID: 13180225
    [No Abstract]   [Full Text] [Related]  

  • 14. AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.
    BAUGH CW
    Can Med Assoc J; 1965 Jan; 92(3):116-20. PubMed ID: 14232183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LABORATORY CONTROL OF ANTICOAGULANT THERAPY.
    LAU KS; SINGH N
    Med J Malaya; 1963 Dec; 18():107-15. PubMed ID: 14117278
    [No Abstract]   [Full Text] [Related]  

  • 17. LABORATORY STUDIES ON PATIENTS RECEIVING ANTICOAGULANT THERAPY.
    SHAW S; PEGRUM GD; WOLFF S
    J Clin Pathol; 1965 May; 18(3):327-9. PubMed ID: 14304246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some biochemical and electrophoretic studies on purified prothrombin, factor VII (proconvertin) and factor X (Stuart).
    TISHKOFF GH; PECHET L; ALEXANDER B
    Blood; 1960 May; 15():778-90. PubMed ID: 13838500
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of coagulation time obtained with the one-stage method according to Quick (prothrombin time) and according to Owren (prothrombin-proconvertin time) in the control of coumarin treatment].
    CLETON FJ
    Ned Tijdschr Geneeskd; 1959 Sep; 103():1835-6. PubMed ID: 13810671
    [No Abstract]   [Full Text] [Related]  

  • 20. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY?
    SAMUELSSON SM; LILIENBERG G
    Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.